Cargando…

Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population

Mucopolysaccharidosis type I (MPS I) was a group of rare autosomal recessive disorder caused by the deficiency of the lysosomal enzyme, alpha -L -iduronidase, and the resulting accumulation of undergraded dematan sulfate and heparan sulfate. MPS I patients have a wide range of clinical presentations...

Descripción completa

Detalles Bibliográficos
Autores principales: Chkioua, Latifa, Khedhiri, Souhir, Ben Turkia, Hadhami, Chahed, Henda, Ferchichi, Salima, Ben Dridi, Marie Françoise, Laradi, Sandrine, Miled, Abdelhedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261812/
https://www.ncbi.nlm.nih.gov/pubmed/22074387
http://dx.doi.org/10.1186/1746-1596-6-113
_version_ 1782221631777669120
author Chkioua, Latifa
Khedhiri, Souhir
Ben Turkia, Hadhami
Chahed, Henda
Ferchichi, Salima
Ben Dridi, Marie Françoise
Laradi, Sandrine
Miled, Abdelhedi
author_facet Chkioua, Latifa
Khedhiri, Souhir
Ben Turkia, Hadhami
Chahed, Henda
Ferchichi, Salima
Ben Dridi, Marie Françoise
Laradi, Sandrine
Miled, Abdelhedi
author_sort Chkioua, Latifa
collection PubMed
description Mucopolysaccharidosis type I (MPS I) was a group of rare autosomal recessive disorder caused by the deficiency of the lysosomal enzyme, alpha -L -iduronidase, and the resulting accumulation of undergraded dematan sulfate and heparan sulfate. MPS I patients have a wide range of clinical presentations, that makes it difficult to predict patient phenotype which is needed for genetic counseling and also impedes the selection and evaluation of patients undergoing therapy bone marrow transplantation. AIM OF THE STUDY: consanguinity rates have been determined among 14 families with mucopolysaccharidosis type I, seen in the pediatric departments of different geographic areas of Tunisia (Central and Southern areas) for the period August 2004 - August 2011 in order to investigate the relation between consanguinity and this disorder. PATIENTS AND METHODS: Clinical and molecular analyses confirmed the diagnosis for MPS type I in the studied families. RESULTS: Most of the Tunisian MPS I patients have been identified at the homozygous status: p.P533R mutation (7 homozygous and one double heterozygous p.L578Q/p.P533R patients; 41.66% of all the investigated MPSI patients), p.F177S (1 homozygous patient; 5.55%), p.L530fs (1 patient; 5.55%), p.Y581X (2 patients; 11.11%), p.F602X (3 patients; 16.66%), p.R628X (1 patient; 5.55%). Another mutation: p.L578Q has been identified at the heterozygous status in the only double heterozygous p.L578Q/p.P533R case. Part of the mutations was the result of a founder effect. These described points are the consequences of the high rate of consanguinity. CONCLUSION: The high frequency of p.P533R mutation could be explained by the high degree of inbreeding. This is due to the richness of the genetic background of the studied population. A multidisciplinary approach is essential to develop adequate preventive program adapted to the social, cultural, and economic context.
format Online
Article
Text
id pubmed-3261812
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32618122012-01-20 Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population Chkioua, Latifa Khedhiri, Souhir Ben Turkia, Hadhami Chahed, Henda Ferchichi, Salima Ben Dridi, Marie Françoise Laradi, Sandrine Miled, Abdelhedi Diagn Pathol Research Mucopolysaccharidosis type I (MPS I) was a group of rare autosomal recessive disorder caused by the deficiency of the lysosomal enzyme, alpha -L -iduronidase, and the resulting accumulation of undergraded dematan sulfate and heparan sulfate. MPS I patients have a wide range of clinical presentations, that makes it difficult to predict patient phenotype which is needed for genetic counseling and also impedes the selection and evaluation of patients undergoing therapy bone marrow transplantation. AIM OF THE STUDY: consanguinity rates have been determined among 14 families with mucopolysaccharidosis type I, seen in the pediatric departments of different geographic areas of Tunisia (Central and Southern areas) for the period August 2004 - August 2011 in order to investigate the relation between consanguinity and this disorder. PATIENTS AND METHODS: Clinical and molecular analyses confirmed the diagnosis for MPS type I in the studied families. RESULTS: Most of the Tunisian MPS I patients have been identified at the homozygous status: p.P533R mutation (7 homozygous and one double heterozygous p.L578Q/p.P533R patients; 41.66% of all the investigated MPSI patients), p.F177S (1 homozygous patient; 5.55%), p.L530fs (1 patient; 5.55%), p.Y581X (2 patients; 11.11%), p.F602X (3 patients; 16.66%), p.R628X (1 patient; 5.55%). Another mutation: p.L578Q has been identified at the heterozygous status in the only double heterozygous p.L578Q/p.P533R case. Part of the mutations was the result of a founder effect. These described points are the consequences of the high rate of consanguinity. CONCLUSION: The high frequency of p.P533R mutation could be explained by the high degree of inbreeding. This is due to the richness of the genetic background of the studied population. A multidisciplinary approach is essential to develop adequate preventive program adapted to the social, cultural, and economic context. BioMed Central 2011-11-10 /pmc/articles/PMC3261812/ /pubmed/22074387 http://dx.doi.org/10.1186/1746-1596-6-113 Text en Copyright ©2011 Chkioua et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Chkioua, Latifa
Khedhiri, Souhir
Ben Turkia, Hadhami
Chahed, Henda
Ferchichi, Salima
Ben Dridi, Marie Françoise
Laradi, Sandrine
Miled, Abdelhedi
Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
title Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
title_full Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
title_fullStr Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
title_full_unstemmed Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
title_short Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
title_sort hurler disease (mucopolysaccharidosis type ih): clinical features and consanguinity in tunisian population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261812/
https://www.ncbi.nlm.nih.gov/pubmed/22074387
http://dx.doi.org/10.1186/1746-1596-6-113
work_keys_str_mv AT chkioualatifa hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT khedhirisouhir hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT benturkiahadhami hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT chahedhenda hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT ferchichisalima hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT bendridimariefrancoise hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT laradisandrine hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation
AT miledabdelhedi hurlerdiseasemucopolysaccharidosistypeihclinicalfeaturesandconsanguinityintunisianpopulation